GALMED PHARMACEUTICALS LTD. (GLMD) Free cash flow 2016–2022
GALMED PHARMACEUTICALS LTD. (GLMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$18.5MFY2022 · since FY2016: -$12.1M → -$18.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$18.5M | +43.8% |
| FY2021 | -$32.9M | -25.0% |
| FY2020 | -$26.3M | -76.1% |
| FY2019 | -$14.9M | -64.0% |
| FY2018 | -$9.1M | +24.6% |
| FY2017 | -$12.1M | +0.6% |
| FY2016 | -$12.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice